肺繊維症 (PF) の総合的なレビュー: 組織学的スペクトル,診断,リスク要因,病原性,分子病理生理学,および現在の治療法
Mohamed A Sadek1,2, Rana M ElBishbishy1, Rana M Lotfy1
1Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
Chemistry & biodiversity
|August 30, 2025
まとめ
肺線維症 (PF) は,酸素交換を阻害する進行性肺の傷跡です. 薬草は有望ですが PFの管理に有効性を検証するには 臨床研究が必要です
科学分野:
- 肺医学
- 病理学について
- 薬理学について
背景:
- 肺線維症 (PF) は,進行的な肺組織の傷つき,ガス交換と酸素供給を危うくする.
- 複数の要因が PFに寄与します 環境からの暴露,自己免疫疾患,感染症,薬剤などです
研究 の 目的:
- 肺線維症の総合的な概要を 提供するためです
- 組織の変化,診断方法,危険因子,生物学的メカニズム,現在のPFの治療法をカバーします.
主な方法:
- 肺線維症に関する既存の研究の文献レビュー.
- 薬草と天然製品の介入に関する臨床前データの分析
主要な成果:
- PFは肺組織の損傷と傷跡で特徴づけられ,ガス交換が減少します.
- 臨床前の証拠は,薬草や天然製品の抗炎症性および抗線維性効果を示唆しています.
結論:
- PFに対する薬草の臨床適用は,十分な証拠がないため,現在限られている.
- PF管理のための補完的な戦略を検証し,最適化するために,さらなる研究が不可欠です.
関連する概念動画
COPD: Pathogenesis and Clinical Features
516
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
516
Pulmonary Hypertension: Classification and Pathogenesis
284
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
284
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K


